Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS at Natera, Inc. (NTRA), sold 5,500 shares at $165.69 ($917K) on 2025-09-02, disclosed to the SEC on 2025-09-05.
Scheduled sale ($917k) by PRESIDENT, CLINICALDIAGNOSTICS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $165.69 | 1,290 | $214K | 23.3% |
| 2 | $165.69 | 1,290 | $214K | 23.3% |
| 3 | $166.39 | 500 | $83K | 9.1% |
| 4 | $167.71 | 1,210 | $203K | 22.1% |
| 5 | $167.71 | 1,210 | $203K | 22.1% |
| Total | $166.64 avg | 5,500 |
| $917K |
| 100% |
| Filing → |
| NTRA | SELL | 2026-08-05 | $906K | — | Filing → |
| NTRA | SELL | 2026-07-29 | $569K | — | Filing → |
| NTRA | SELL | 2026-07-06 | $819K | — | Filing → |